Karen I. Norton

A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety Studies

Christine M. Eng, Maryam Banikazemi, Ronald E. Gordon et al. · The American Journal of Human Genetics · 2001 · 383 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Mutations in Capillary Morphogenesis Gene-2 Result in the Allelic Disorders Juvenile Hyaline Fibromatosis and Infantile Systemic Hyalinosis

Oonagh Dowling, Analisa DiFeo, Maria Celeste M. Ramirez et al. · The American Journal of Human Genetics · 2003 · 196 citations · Full text

Medicine, Genetics, Molecular Genetics +10

New Approach to the Management of Airway Obstruction in "High Risk" Neonates

Peter J. Catalano, Mark L. Urken, Karen I. Norton et al. · Archives of Otolaryngology - Head and Neck Surgery · 1992 · 105 citations

Medicine, Pediatrics, Surgery +14

MR Cholangiography in the Evaluation of Neonatal Cholestasis: Initial Results

Karen I. Norton, Ronald B. J. Glass, Debora Kogan et al. · Radiology · 2002 · 101 citations

Medicine, Pediatrics, Radiology +17

Congenital rickets associated with magnesium sulfate infusion for tocolysis

Carin Lamm, Karen I. Norton, Ramon Murphy et al. · The Journal of Pediatrics · 1988 · 82 citations

Medicine, Pediatric Pharmacy, Pediatrics +9